Peter Ding is a highly accomplished professional with over 20 years of expertise in small molecule drug discovery. He possesses a strong background in innovative drug preclinical research and development, as well as an in-depth understanding of companion diagnosis strategy, IND filing processes in the US and China, and early stage dose escalation and POC clinical trials.Peter is also a co-founder of two reputable biotech startup companies, Curegenix and Allorion Therapeutics. His entrepreneurial spirit and strategic leadership have played a pivotal role in driving these ventures towards success.